Citations 1
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease
Weaver, Kimberly N. , Zhang, Xian , Dai, Xiangfeng , Chen, Wenli , Watkins, Runa , Adler, Jeremy, Dubinsky, Marla C. , Kastl, Arthur , Bousvaros, Athos, Strople, Jennifer , Higgins, Peter , Bewtra, Meenakshi , Bellaguarda, Emanuelle, Craig, Riley, Hernandez, Cristian, Boccieri, Margie , Firestine, Ann M. , Chun, Kelly , Long, Millie D. , Cross, Raymond , Adler, Jeremy, Cross, Raymond K. , Ungaro, Ryan C. , Farraye, Francis A. , Kappelman, Michael D. , Adler, J
Inflammatory Bowel Diseases | July 13, 2022 | Volume: 29 | Issue: 3 | Pages: 483-486
Lay SummaryWe demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute respiratory syndrome coronavirus 2 vaccination in a large cohort of inflammatory bowel disease patients. Residence in southern United States and lower median anti-receptor binding antibody level were associated with development of COVID-19.